Big brokers think these 5 ASX shares can outperform the market

Mineral Resources (ASX: MIN) and 3P Learning (ASX: 3PL) are among 5 ASX shares that brokers say could outperform the market today

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Big brokers have run the ruler on ASX shares that could beat the market. Here are the ones that have been rated as a buy or buy equivalent on Tuesday.

Five stars

Image source: Getty Images

ASX shares that could outperform the market 

3P Learning Ltd (ASX: 3PL

3P Learning announced on Monday that it will acquire 100% of Blake eLearning to emerge as a leading educational technology platform. 

Morgan Stanley views this as a positive transaction in terms of scale, product mix, customer mix and potential for meaningful revenue and cost synergies. 

The broker's commentary does note some slight caution towards Blake eLearning, which seems to be cycling a period of accelerated COVID-19 sign-up. This could result in a higher churn rate and flatter growth in the near term. 

Morgan Stanley maintained its overweight rating and increased its target price from $1.50 to $1.60. 3P Learning shares are currently trading at $1.30. 

Aristocrat Leisure Ltd (ASX: ALL

Aristocrat Leisure has arguably received the most broker updates of all ASX shares this month. This includes updates from April 7, April 9 and April 13. The big broker narrative typically highlights a bounce back in its core casino machines business and acceleration in its digital gaming revenues. 

On Tuesday, Credit Suisse points out that Apple Inc (NASDAQ: AAPL) was named the defendant in six lawsuits filed in United States federal courts alleging casino-style app games that allow users to purchase virtual coins, and pay money to win more playing time, constitutes unlawful gambling in certain US states.

The broker believes that Apple may have to restrict or alter its distribution of mobile gambling games. 

Overall, Credit Suisse remains bullish on Aristocrat shares, retaining an outperform rating and $38.00 target price. The Aristocrat share price is currently fetching $36.14, within arm's reach of its all-time record high of $38.00. 

BlueScope Steel Limited (ASX: BSL

Macquarie upgraded its earnings estimates in the second half to $919.4 million. The broker believes a rally in steel prices have been underpinned by favourable market dynamics including a consolidating global steel industry, high utilisation and strong demand. 

Macquarie's commentary notes that there are risks associated with a potential rollover of steel prices, but believes strong earnings momentum can continue in the near term.

An outperform rating was retained and target price raised from $21.65 to $23.50. BlueScope shares are currently trading at $20.30. 

Mach7 Technologies Ltd (ASX: M7T

The Mach7 share price jumped as much as 14% yesterday after the company announced record quarterly results. After assessing the third-quarter results, Morgan Stanley was pleased with its $12.8 million in new sales orders for the quarter from both new and existing customers. This represents a significant uplift from the $7.6 million in the second quarter. 

The broker made no changes to its forecasts, retaining an add rating with a $1.68 target price. Mach7 shares have retreated 2.55% on Tuesday to $1.34. 

Mineral Resources Limited (ASX: MIN

Macquarie upgraded a number of ASX lithium shares on Tuesday including heavyweights Galaxy Resources Limited (ASX: GXY), Orocobre Ltd (ASX: ORE) and Pilbara Minerals Ltd (ASX: PLS). 

The broker lifted its lithium price outlook and expects Mineral Resources' to begin producing lithium hydroxide in FY22. Macquarie believes that buoyant iron ore prices will support Mineral Resources in the near term while its entry into lithium production will drive medium to long term value. 

Macquarie rates Mineral Resources as outperform and lifted its target price from $50 to $61. Mineral Resources shares are currently trading at $40.85. 

Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends MACH7 FPO. The Motley Fool Australia has recommended MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »